CAL
AMPE

Capital Analysts LLC’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Capital Analysts LLC’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33
Closed -$6K – 769
2020
Q2 		$6K Hold
33
– – ﹤0.01% 596
2020
Q1 		$4K Hold
33
– – ﹤0.01% 610
2019
Q4 		$6K Hold
33
– – ﹤0.01% 609
2019
Q3 		$5K Hold
33
– – ﹤0.01% 620
2019
Q2 		$4K Hold
33
– – ﹤0.01% 601
2019
Q1 		$5K Hold
33
– – ﹤0.01% 576
2018
Q4 		$4K Hold
33
– – ﹤0.01% 524
2018
Q3 		$5K Buy
+33
New +$13.8K ﹤0.01% 487

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital Analysts LLC's AMPE Position: Q3 2020 in Review

Capital Analysts LLC sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2020, closing a stake of 33 shares — an estimated $6K sold.

Capital Analysts LLC first reported a position in AMPE in Q3 2018 and held it in 8 quarters. The position peaked at $6K in Q2 2020. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2020.

  • Capital Analysts LLC reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2020 after selling out during the quarter.
  • Capital Analysts LLC sold 33 Ampio Pharmaceuticals Inc. shares in Q3 2020, an estimated $6K.
  • Capital Analysts LLC first reported a position in Ampio Pharmaceuticals Inc. in Q3 2018 and held it in 8 quarters.
  • Capital Analysts LLC's Ampio Pharmaceuticals Inc. position peaked at $6K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2020.

Based on Capital Analysts LLC's 13F filing for Q3 2020, filed 12 Nov 2020.